Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
PIONEERING SMALL MOLECULE THERAPEUTICS
Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)
Homepage
Displayed as investors on the website
Droia Ventures · SSI Strategy · RTW · Novartis Venture Fund · RV Invest · Frazier Life Sciences
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
April 2026 – November 2026 · 3 captures · latest observed messagingSmall molecules, life-changing power.
Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases.
23 April 2026 · Small molecules, life-changing power.archived page
25 August 2026 · Small molecules, life-changing power.archived page
6 November 2026 · Small molecules, life-changing power.current websiteHistorical capture not publicly available
July 2025 – October 2025 · 2 capturesPIONEERING SMALL MOLECULE THERAPEUTICS
Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)